The New Frontier in Ophthalmic Care

Smartlens is redefining anterior segment disease management through breakthrough technologies for continuous monitoring, diagnosis, and treatment optimization — starting with glaucoma, the leading cause of irreversible blindness worldwide.

• miLens™ — the world's smallest wearable microfluidic contact lens for remote, electronics-free intraocular pressure (IOP) monitoring. In U.S. pivotal trials.
• miLens IQ+™ — AI/ML analytics platform for diurnal IOP and imaging data.
• Smartlens Anterior Segment Platform — AI-powered remote examination for dry eye, cataracts, uveitis, and other anterior segment conditions. In U.S. pivotal trials.
• THERx IQ™ — automated micro-dose medication delivery for chronic eye disease. In pilot trials.

• 🌐 Website: smartlens.health
• 👁️ About: smartlens.health/about
• 👥 Team: smartlens.health/team
• 🔑 Request access: smartlens.health/access
• ✉️ Contact: smartlens.health/contact
• 💼 LinkedIn: @smartlens-health

Building a world where glaucoma and other anterior segment diseases no longer steal vision.